[{"NetIncomeLoss_1_Q1_USD":86000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"InventoryGross_0_Q1_USD":65385000.0,"AccruedRoyaltiesCurrent_0_Q1_USD":5310000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":34451000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":2381000.0,"TreasuryStockCommonShares_0_Q1_shares":86035.0,"InterestPaidNet_1_Q1_USD":1983000.0,"InventoryFinishedGoods_0_Q1_USD":21791000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-5032000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":5000000.0,"IncomeTaxesPaid_1_Q1_USD":112000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-737000.0,"OperatingLeaseLiability_0_Q1_USD":382000.0,"GoodwillImpairmentLoss_1_Q1_USD":0.0,"InterestRateDerivativeLiabilitiesAtFairValue_0_Q1_USD":8122000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":56000.0,"AssetsCurrent_0_Q1_USD":182798000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":13000.0,"LongTermDebtCurrent_0_Q1_USD":14438000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":17587000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":1700000.0,"ResearchAndDevelopmentInProcess_1_Q1_USD":0.0,"InventoryValuationReserves_0_Q1_USD":5458000.0,"InterestExpenseDebtExcludingAmortization_1_Q1_USD":2304000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":82000.0,"Assets_0_Q1_USD":463843000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":6405000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":-2454000.0,"TreasuryStockCommonValue_0_Q1_USD":2594000.0,"Liabilities_0_Q1_USD":260131000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":250000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":2968000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":418000.0,"InventoryRawMaterials_0_Q1_USD":39746000.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":-379000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":176311000.0,"EarningsPerShareBasic_1_Q1_USD":0.01,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":35199000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":12017000.0,"PrepaidExpenseCurrent_0_Q1_USD":5922000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-515000.0,"AccountsReceivableNetCurrent_0_Q1_USD":91876000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-10000.0,"NumberOfReportableSegments_1_Q1_segment":1.0,"CommonStockValue_0_Q1_USD":1000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1_Q1_USD":115000.0,"ProceedsFromLinesOfCredit_1_Q1_USD":0.0,"TreasuryStockValueAcquiredCostMethod_1_Q1_USD":348000.0,"InterestCostsCapitalizedAdjustment_1_Q1_USD":26000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":10898000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.277,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-2725000.0,"CostsAndExpenses_1_Q1_USD":51476000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-876000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":81000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":6491000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":2462000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":9700000.0,"OtherAssetsNoncurrent_0_Q1_USD":833000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":25073000.0,"ShareBasedCompensation_1_Q1_USD":1869000.0,"RetailRelatedInventoryPackagingAndOtherSupplies_0_Q1_USD":3066000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_1_Q1_USD":-5000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":18774000.0,"Goodwill_0_Q1_USD":3580000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":76000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":1869000.0,"ValuationAllowancesAndReservesBalance_0_Q1_USD":80722000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":20668000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":12004000.0,"InventoryWorkInProcess_0_Q1_USD":782000.0,"CostOfRevenue_1_Q1_USD":19985000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":127000.0,"LiabilitiesCurrent_0_Q1_USD":82768000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":17206000.0,"AccountsPayableCurrent_0_Q1_USD":13769000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":31474000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":30073000.0,"DeferredIncomeTaxesAndTaxCredits_1_Q1_USD":-279000.0,"LongTermDebtNoncurrent_0_Q1_USD":168985000.0,"InterestExpenseDebt_1_Q1_USD":2455000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":3659000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":178859000.0,"RepaymentsOfOtherLongTermDebt_1_Q1_USD":2377000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q1_USD":81000.0,"AdditionalPaidInCapital_0_Q1_USD":216223000.0,"PaymentsToAcquireIntangibleAssets_1_Q1_USD":39000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":178859000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":218000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":40767000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":0.0,"AmortizationOfFinancingCosts_1_Q1_USD":177000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":100000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q1_USD":10700000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":36000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":54521000.0,"OperatingIncomeLoss_1_Q1_USD":3045000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q1_USD":6405000.0,"InventoryNet_0_Q1_USD":59927000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":62000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":355170000.0,"PreferredStockValue_0_Q1_USD":null,"OperatingLeaseCost_1_Q1_USD":49000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":463843000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":5533000.0,"PreferredStockSharesAuthorized_0_Q1_shares":1666667.0,"DeferredTaxAssetsValuationAllowance_0_Q1_USD":300000.0,"ImpairmentOfIntangibleAssetsFinitelived_1_Q1_USD":0.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":59541000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":132000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":28954000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":8378000.0,"StockholdersEquity_0_Q1_USD":203712000.0,"IncreaseDecreaseInIncomeTaxes_1_Q1_USD":-247000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":698000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":572000.0,"VariableLeaseCost_1_Q1_USD":7000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-4886000.0,"LeaseCost_1_Q1_USD":56000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-3917000.0,"UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_1_Q1_USD":-5000.0,"EarningsPerShareDiluted_1_Q1_USD":0.01,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":28127000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":52006000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":110000.0,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210507"}]